Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

ImmuCell Corporation (ICCC) had Revenue of $6.44M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$6.44M
Net Income	$0.50M
Cost of Goods Sold	$3.63M
Gross Profit	$2.82M
Operating Expenses	$5.88M
Operating Income	$0.57M
Non-Operating Income/Expense	$-0.07M
Pre-Tax Income	$0.50M
Normalized Pre-Tax Income	$0.50M
Income after Taxes	$0.50M
Income from Continuous Operations	$0.50M
Consolidated Net Income/Loss	$0.50M
Normalized Income after Taxes	$0.50M
EBIT	$0.57M
EBITDA	$1.25M
Weighted-Average Shares Outstanding (Basic)	9.03M
Weighted-Average Shares Outstanding (Diluted)	9.03M
Earnings per Share (EPS) (Basic)	$0.06
Earnings per Share (EPS) (Diluted)	$0.06
Balance Sheet Financials
Current Assets	$17.14M
Property, Plant, and Equipment	$24.88M
Long-Term Assets	$29.58M
Total Assets	$46.72M
Current Liabilities	$4.45M
Long-Term Debt	$8.26M
Long-Term Liabilities	$12.41M
Total Liabilities	$16.85M
Common Equity	$29.87M
Tangible Shareholders Equity	$29.76M
Shareholders Equity	$29.87M
Common Shares Outstanding	9.05M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.18M
Cash Flow from Investing Activities	$-0.46M
Cash Flow from Financial Activities	$-0.48M
Beginning Cash	$3.76M
End Cash	$6.00M
Increase/Decrease in Cash	$2.24M
Stock-Based Compensation	$0.12M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.85
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.22
Debt to Equity Ratio	0.33
Gross Margin	43.72%
Operating Margin	8.84%
EBIT Margin	8.84%
EBITDA Margin	--
Pre-Tax Profit Margin	7.82%
Profit Margin	7.79%
Free Cash Flow	$2.72M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.44
Receiveable Turnover	2.71
Days Sales in Receivables	33.22
Return on Equity	1.68%
Return on Tangible Equity	1.69%
Return on Assets	1.07%
Return on Investments	1.32%
Book Value Per Share	$3.30
Free Cash Flow per Share	$0.30
Operating Cash Flow per Share	$0.35

Data from Zacks Investment Research, Inc.